Improvements in urticaria control and quality of life among patients with chronic inducible urticaria were observed with 20 ...

NVS wins CHMP backing for remibrutinib in chronic spontaneous urticaria, bringing its oral BTK inhibitor closer to EU approval.

Sustained off-treatment efficacy despite barzolvolimab clearance and normalization of tryptase, suggesting disease modification in patients ...

In a phase 2 trial, patients having an urticaria exacerbation who used the spray report better hive and pruritus scores than the placebo group.

Regeneron and Sanofi win CHMP backing to expand Dupixent use to young CSU patients, with EU and U.S. decisions poised to unlock a new growth avenue.

Patients with chronic spontaneous urticaria had positive outcomes weeks after barzolvolimab, according to data presented at ...

Common comorbidities in all patients with urticaria included allergic rhinitis, allergic asthma, allergic conjunctivitis, atopic dermatitis, Helicobacter pylori infection, and parasitic infection. The ...

Unlike allergic hives, chronic spontaneous urticaria (CSU) stems from immune system dysregulation and can persist for months or years, requiring ongoing management. Patients should understand that CSU ...

A woman in California has said she is battling with a condition that makes her allergic to water. Tessa Hansen-Smith, 25, told ABC News she developed Aquagenic Urticaria when she was just eight years ...